On Monday, C4 Therapeutics got an upgrade to its Relative Strength Rating, from 76 to 84. The RS Rating over 80 makes C4 Therapeutics stock one to watch. When looking for the best stocks to buy and watch, keep a close on eye on relative price strength.
Read More
